Metal-based inhibitors that have been tested in models of cancer include AQP3 inhibitors such as NiCl2 (Zelenina et al., 2003) and CuSO4 (Zelenina et al., 2004), which inhibited EGF-induced cell migration in human ovarian cancer cells. This evidence concerns the gene AQP3 and ovarian carcinoma.